325 related articles for article (PubMed ID: 33386466)
1. The subtle interplay between gamma delta T lymphocytes and dendritic cells: is there a role for a therapeutic cancer vaccine in the era of combinatorial strategies?
Galati D; Zanotta S; Bocchino M; De Filippi R; Pinto A
Cancer Immunol Immunother; 2021 Jul; 70(7):1797-1809. PubMed ID: 33386466
[TBL] [Abstract][Full Text] [Related]
2. Empowering dendritic cell cancer vaccination: the role of combinatorial strategies.
Galati D; Zanotta S
Cytotherapy; 2018 Nov; 20(11):1309-1323. PubMed ID: 30360963
[TBL] [Abstract][Full Text] [Related]
3. Enhanced ability of dendritic cells to stimulate innate and adaptive immunity on short-term incubation with zoledronic acid.
Fiore F; Castella B; Nuschak B; Bertieri R; Mariani S; Bruno B; Pantaleoni F; Foglietta M; Boccadoro M; Massaia M
Blood; 2007 Aug; 110(3):921-7. PubMed ID: 17403919
[TBL] [Abstract][Full Text] [Related]
4. Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells.
Schnurr M; Scholz C; Rothenfusser S; Galambos P; Dauer M; Röbe J; Endres S; Eigler A
Cancer Res; 2002 Apr; 62(8):2347-52. PubMed ID: 11956095
[TBL] [Abstract][Full Text] [Related]
5. Dendritic Cells Are Critical for the Activation and Expansion of Vδ2
Wang X; Liu J; Gao H; Mo XD; Han T; Xu LP; Zhang XH; Huang XJ
Front Immunol; 2018; 9():2528. PubMed ID: 30443256
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell cross talk with innate and innate-like effector cells in antitumor immunity: implications for DC vaccination.
van Beek JJ; Wimmers F; Hato SV; de Vries IJ; Sköld AE
Crit Rev Immunol; 2014; 34(6):517-36. PubMed ID: 25597314
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
8. Immune suppression by gammadelta T-cells as a potential regulatory mechanism after cancer vaccination with IL-12 secreting dendritic cells.
Traxlmayr MW; Wesch D; Dohnal AM; Funovics P; Fischer MB; Kabelitz D; Felzmann T
J Immunother; 2010 Jan; 33(1):40-52. PubMed ID: 19952957
[TBL] [Abstract][Full Text] [Related]
9. The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy.
Liu Y; Zhang C
Cells; 2020 May; 9(5):. PubMed ID: 32413966
[TBL] [Abstract][Full Text] [Related]
10. The plasticity of gamma delta T cells: innate immunity, antigen presentation and new immunotherapy.
Casetti R; Martino A
Cell Mol Immunol; 2008 Jun; 5(3):161-70. PubMed ID: 18582397
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-15-Cultured Dendritic Cells Enhance Anti-Tumor Gamma Delta T Cell Functions through IL-15 Secretion.
Van Acker HH; Anguille S; De Reu H; Berneman ZN; Smits EL; Van Tendeloo VF
Front Immunol; 2018; 9():658. PubMed ID: 29692776
[TBL] [Abstract][Full Text] [Related]
12. Immune modulation by zoledronic acid in human myeloma: an advantageous cross-talk between Vγ9Vδ2 T cells, αβ CD8+ T cells, regulatory T cells, and dendritic cells.
Castella B; Riganti C; Fiore F; Pantaleoni F; Canepari ME; Peola S; Foglietta M; Palumbo A; Bosia A; Coscia M; Boccadoro M; Massaia M
J Immunol; 2011 Aug; 187(4):1578-90. PubMed ID: 21753152
[TBL] [Abstract][Full Text] [Related]
13. Tumor-derived γδ regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence.
Ye J; Ma C; Hsueh EC; Eickhoff CS; Zhang Y; Varvares MA; Hoft DF; Peng G
J Immunol; 2013 Mar; 190(5):2403-14. PubMed ID: 23355732
[TBL] [Abstract][Full Text] [Related]
14. Cancer immunotherapy with γδ T cells: many paths ahead of us.
Kabelitz D; Serrano R; Kouakanou L; Peters C; Kalyan S
Cell Mol Immunol; 2020 Sep; 17(9):925-939. PubMed ID: 32699351
[TBL] [Abstract][Full Text] [Related]
15. Function of γδ T cells in tumor immunology and their application to cancer therapy.
Park JH; Lee HK
Exp Mol Med; 2021 Mar; 53(3):318-327. PubMed ID: 33707742
[TBL] [Abstract][Full Text] [Related]
16. Human Vγ9/Vδ2 T cells: Innate adaptors of the immune system.
Tyler CJ; Doherty DG; Moser B; Eberl M
Cell Immunol; 2015 Jul; 296(1):10-21. PubMed ID: 25659480
[TBL] [Abstract][Full Text] [Related]
17. Zoledronate-activated Vγ9γδ T cell-based immunotherapy is feasible and restores the impairment of γδ T cells in patients with solid tumors.
Noguchi A; Kaneko T; Kamigaki T; Fujimoto K; Ozawa M; Saito M; Ariyoshi N; Goto S
Cytotherapy; 2011 Jan; 13(1):92-7. PubMed ID: 20831354
[TBL] [Abstract][Full Text] [Related]
18. Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression.
Stolk D; van der Vliet HJ; de Gruijl TD; van Kooyk Y; Exley MA
Front Immunol; 2018; 9():1990. PubMed ID: 30298063
[TBL] [Abstract][Full Text] [Related]
19. The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting.
Li Y; Li G; Zhang J; Wu X; Chen X
Front Immunol; 2020; 11():619954. PubMed ID: 33664732
[TBL] [Abstract][Full Text] [Related]
20. Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses.
Brandes M; Willimann K; Bioley G; Lévy N; Eberl M; Luo M; Tampé R; Lévy F; Romero P; Moser B
Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2307-12. PubMed ID: 19171897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
